GeneDx Holdings Corp. (WGS) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $2.71B, a trailing price-to-earnings ratio of 252.2 and a free-cash-flow yield of 0.6%. Over the most recent reported fiscal year, revenue grew 40.0%.